5-thien-2-yl-2',3',5'-tri-O-acetylarabinofuranosyluracil | 146629-40-5

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: 5-thien-2-yl-2',3',5'-tri-O-acetylarabinofuranosyluracil
• CAS: 146629-40-5
• 化学式: C₁₉H₂₀N₂O₉S
• 分子量: 452.442
• InChiKey: VPFWYMTZLTYYEZ-NYCLONFESA-N

物化性质

• 密度：
  1.47±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.59
• 重原子数：
  31.0
• 可旋转键数：
  6.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  142.99
• 氢给体数：
  1.0
• 氢受体数：
  11.0

反应信息

• 作为反应物：
  描述：

  5-thien-2-yl-2',3',5'-tri-O-acetylarabinofuranosyluracil 在 氨 作用下， 以 甲醇 为溶剂， 生成 5-thien-2-yl-1-(β-D-arabinofuranos-1-yl)uracil
  参考文献：
  名称：

  5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication

  摘要：

  2'-Deoxyuridines with a five-membered heterocyclic substituent in the 5-position were synthesized by palladium-catalyzed coupling reactions of 5-iodo-2'-deoxyuridine with the activated heteroaromatics. Further modification of the compound with the 5-thien-2-yl substituent gave 5-(5-bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothienyl-2-yl)-2'-deoxyuridine. Both compounds show potent and selective activity against herpes simplex virus type 1 and varicella-zoster virus.

  DOI：

  10.1021/jm00112a011
• 作为产物：
  描述：

  2-三丁基甲锡烷基噻吩 、 1-(2,3,5-tri-O-acetyl-β-D-arabinofuranosyl)-5-iodouracil 在 四(三苯基膦)钯 作用下， 以 甲苯 为溶剂， 反应 22.0h， 生成 5-thien-2-yl-2',3',5'-tri-O-acetylarabinofuranosyluracil
  参考文献：
  名称：

  5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication

  摘要：

  2'-Deoxyuridines with a five-membered heterocyclic substituent in the 5-position were synthesized by palladium-catalyzed coupling reactions of 5-iodo-2'-deoxyuridine with the activated heteroaromatics. Further modification of the compound with the 5-thien-2-yl substituent gave 5-(5-bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothienyl-2-yl)-2'-deoxyuridine. Both compounds show potent and selective activity against herpes simplex virus type 1 and varicella-zoster virus.

  DOI：

  10.1021/jm00112a011

文献信息

• Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogs
  作者：Piet Wigerinck、Luc Kerremans、Paul Claes、Robert Snoeck、Prabhat Maudgal、Erik De Clercq、Piet Herdewijn

  DOI：10.1021/jm00057a003

  日期：1993.3

  reagents and palladium complexes as catalyst. The palladium-catalyzed cross-coupling reaction between 5-iodo-2'-deoxyuridine and stannylated heteroaromatics was optimized for the synthesis of the 5-thien-3-yl-2'-deoxyuridine and 5-furan-3-yl-2'-deoxyuridine. 5-(5-Iodothien-2-yl)-2'-deoxyuridine was used as starting material for the synthesis of 5-(5-methylthien-2-yl)-2'-deoxyuridine, 5-(5-vinylthien-2-yl)-2'-deoxyuridine

  使用四有机锡试剂和钯配合物作为催化剂，由5-碘-2'-脱氧尿苷合成了许多5-杂芳族取代的2'-脱氧尿苷。优化了5-碘-2'-脱氧尿苷与锡烷基化杂芳族化合物之间的钯催化的交叉偶联反应，以合成5-噻吩-3-基-2'-脱氧尿苷和5-呋喃-3-基-2' -脱氧尿苷。5-（5-碘噻吩-2-基）-2'-脱氧尿苷用作合成5-（5-甲基噻吩-2-基）-2'-脱氧尿苷，5-（5-乙烯基噻吩-2）的起始原料-基）-2'-脱氧尿苷和5-（5-乙炔基噻吩-2-基）-2'-脱氧尿苷。以硝酸铈铵为试剂合成了5-（5-硝基噻吩-2-基）-2'-脱氧尿苷。由5-（3-氧代丙炔-1-基）-2′-脱氧尿苷合成5-（异恶唑-5-基）-2′-脱氧尿苷。最后，通过将5-噻吩-2-基-β-卤化得到5-（5-氯噻吩-2-基）-β-D-阿拉伯呋喃糖基尿嘧啶和5-（5-溴噻吩-2-基）-β-D-阿拉伯呋喃糖基尿嘧啶。 D-阿拉伯呋喃糖基尿